Pure Global

Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets - Trial NCT01957345

Access comprehensive clinical trial information for NCT01957345 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Toulouse and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 322 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT01957345
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT01957345
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets
Multicentre Evaluation of a New Laboratory Approach for the Diagnosis of Constitutional Functional Disorders of Platelets

Study Focus

Platelet Dysfunction

Blood punction

Interventional

other

Sponsor & Location

University Hospital, Toulouse

Toulouse, France

Timeline & Enrollment

N/A

Feb 01, 2013

Jun 29, 2017

322 participants

Primary Outcome

standardise the method between clinical laboratories

Summary

The primary purpose of the study is to evaluate a standardized method of screening for
 platelet signalling defects in patients with constitutional disorders of platelet function of
 unknown origin. We hypothesize that such defects are under-diagnosed in patients, due to
 heavy workup and requirement of relatively large blood sample by conventional biochemical
 methods. We propose to analyse kinase signalling downstream platelet membrane receptors using
 multiplex flow cytometry quantification and fluorescent platelet barcoding.

ICD-10 Classifications

Qualitative platelet defects
Antithrombotic drugs [platelet-aggregation inhibitors]
Essential (haemorrhagic) thrombocythaemia
Other thrombophilia
Haemorrhagic disorder due to circulating anticoagulants

Data Source

ClinicalTrials.gov

NCT01957345

Non-Device Trial